MedTrace Logo

Severe Anemia Treatment Trials, Pakistan

NCT00116493 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1009

Last updated 2012-04-09

No results posted yet for this study

Summary

The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.

Conditions

Interventions

DIETARY_SUPPLEMENT

Iron-folic acid and mebendazole

100 mg iron for pregnant women, 25 mg iron for children 1 mg of folic acid for pregnant women, 100 ug folic acid for children 500 mg of mebendazole for both pregnant women and children

DRUG

Mebendazole

100 mg twice a day for 3 days; Iron-folic acid also given

DIETARY_SUPPLEMENT

Multivitamins

Iron-folic acid also given; Includes vitamins A, C, B12, E, and B2

DRUG

Mebendazole + Multivitamin

Multivitamins + Mebendazole at 100 mg twice a day for 3 days; Iron-folic acid also given

Sponsors & Collaborators

  • Aga Khan University

    collaborator OTHER

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Parul Christian, DrPH · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
6 Months
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00116493 on ClinicalTrials.gov